LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹131 Cr | ₹117 Cr | ₹96 Cr | ₹111 Cr | ₹95 Cr |
What is the latest Total Current Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹131 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹96 Cr |
| Mar2022 | ₹111 Cr |
| Mar2021 | ₹95 Cr |
How is Total Current Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹131 Cr | 11.65 | |
| Mar2024 | ₹117 Cr | 22.29 | |
| Mar2023 | ₹96 Cr | -13.27 | |
| Mar2022 | ₹111 Cr | 16.80 | |
| Mar2021 | ₹95 Cr | - | |
Compare Total Current Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,252.7 Cr | 2.7% | -15.5% | 6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.7% |
-15.5% |
6.7% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses